Convert physiological signals into clinical insights
Optimise human capability and recovery
Unlock neural signal patterns for discovery
Restore voice and independence through neural access
Control Bionics is all set to launch its NeuroNode Trilogy technology in Japan in partnership with major assistive technology distributor, Double R&D Co Ltd, under an initiative led by CBL’s Japanese executive, Erica Kitayama.
CBL has advanced the deal to provide its technology benefits to Japanese people with medical conditions such as ALS, cerebral palsy, intellectual disability, stroke and traumatic brain injuries.
At Control Bionics, we are dedicated to providing AAC technology that adapts to your unique needs. Through our partnership with IRISBOND, we are proud to distribute the Oskol 2, a sophisticated speech-generating device designed exclusively for the 13″ iPad Air. The...
The intersection of sports science and technological innovation was on full display at the PEAK 2026 conference in Las Vegas. For the Control Bionics team, the event served as a premier platform to demonstrate how our latest advancements are reshaping the landscape of...
Managing complex daily routines can be a significant hurdle for individuals with cognitive or developmental disabilities. Imagine then, the added stress of communicating in unfamiliar and emotional situations like incident investigations into potential crimes or...